JENKINTOWN, PA, April 20, 2004 – The National Comprehensive Cancer Network (NCCN), an alliance of nineteen of the world’s leading cancer centers, announces an update of the NCCN Colorectal Clinical Practice Guidelines. NCCN’s Colon, Rectal, and Anal Cancer panel met recently to discuss incorporation of two newly approved agents into treatment regimens for advanced colon and rectal cancer and to modify recommendations for adjuvant therapy for node positive colon cancer.
Major changes include:
“NCCN Clinical Practice Guidelines in Oncology are widely recognized as the standard for clinical policy in oncology. Additionally, they are being used increasingly by managed care companies to help establish coverage policy,” said William T. McGivney, PhD, Chief Executive Officer of NCCN. “As such, the NCCN recognizes its responsibility to provide up-to-date information to inform decision-making. Thus, the NCCN Guidelines process is an ongoing, continual process.”
The most up-to-date versions of the NCCN Clinical Practice Guidelines in Oncology are available free of charge at www.nccn.org. Additionally, CD-ROMs of the NCCN Complete Library of Clinical Practice Guidelines can be ordered both on the NCCN Web site and by calling 215-690-0300.